Vonoprazan-Based Triple Therapy in Comparison With Extended Sequential Therapy
Key facts
- Who runs it
- Fu Jen Catholic University Hospital
- Where
- Taiwan1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 4
- People taking part
- 628 people enrolled
- Started
- 1 Dec 2021
- Ended
- 28 Feb 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Vonoprazan-based triple therapy
- Extended sequential therapy
- Record updated
- 17 July 2026
Who can take part
- Age
- 20 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Patients with H.pylori infection who was over 20 years old and agree to participate in the trial will be recruited
Who cannot take part
- Who had received helicobacter pylori eradication before
- Who are known to be allergic to any drug used in this trial
- Pregnant women
- Who are refuse to participate in the trial for any reason
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to compare the efficacy of the current standard first-line anti-helicobacter pylori regimen, extended proton pump inhibitor-based sequential therapy, with that of vonoprazan-based triple therapy, through a randomized controlled trial.
The 2 groups in the trial
- Vonoprazan-based triple therapy groupTreatment being tested
Including patients receiving vonoprazan-based triple therapy (vonoprazan 20mg + amoxicillin 1000 mg + clarithromycin 500 mg twice daily for seven days)
Treatment: Vonoprazan-based triple therapy
- Extended sequential therapy groupExisting treatment, for comparison
Including patients receiving extended sequential therapy (lansoprazole 30mg + amoxicillin 1000mg twice daily for 7 days, followed by lansoprazole 30mg + clarithromycin 500mg + metronidazole 500mg twice daily for 7 days)
Treatment: Extended sequential therapy
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Seven-Day Vonoprazan-Based Triple Therapy With High-Dose Amoxicillin as First-Line Helicobacter Pylori Treatment in Comparison With Extended Sequential Therapy: A Randomized Controlled Trial in Taiwan
- Publications
- Record updated
- 17 July 2026